← Back to Search

Exercise Therapy for Cancer and COVID-19 Recovery

Phase 1
Waitlist Available
Led By Jessica Scott, PhD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age ≥ 18
Women <50 years old who are of child-bearing potential must have a negative pregnancy test within 14 days of enrollment.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 weeks
Awards & highlights

Study Summary

This trial will evaluate the safety of an aerobic exercise therapy program for cancer patients recovering from COVID-19. The therapy being used is a walking program that will be adjusted to match participant fitness levels.

Who is the study for?
This trial is for adults over 18 who have had cancer, are recovering from COVID-19, and do less than 90 minutes of exercise a week. They must have space for a treadmill at home and be cleared to exercise. Women able to have children must not be pregnant or planning pregnancy during the study.Check my eligibility
What is being tested?
The trial tests a 30-week walking program tailored to fitness levels in cancer patients recovering from COVID-19. It aims to see if this aerobic exercise therapy is safe and causes few or mild side effects.See study design
What are the potential side effects?
Since the intervention involves aerobic exercise, potential side effects may include muscle soreness, fatigue, joint pain, or shortness of breath. However, these are expected to be mild as the program matches participant fitness levels.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am a woman under 50, can become pregnant, and have a recent negative pregnancy test.
Select...
I am not pregnant nor planning to become pregnant during the study.
Select...
It's been 1-10 years since I finished my primary cancer treatment, but I may still be on hormone therapy.
Select...
I was hospitalized due to Covid-19.
Select...
I was discharged from the hospital more than 30 days ago.
Select...
I have room for a treadmill at home.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Frequency of serious adverse events during study-related assessments

Trial Design

1Treatment groups
Experimental Treatment
Group I: Participants who were hospitalized for COVID-19Experimental Treatment1 Intervention
Participants will be post-cancer treatment patients who were hospitalized for COVID-19.

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,933 Previous Clinical Trials
585,617 Total Patients Enrolled
Jessica Scott, PhDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
6 Previous Clinical Trials
837 Total Patients Enrolled

Media Library

Aerobic Exercise Therapy Clinical Trial Eligibility Overview. Trial Name: NCT04824443 — Phase 1
Coronavirus Research Study Groups: Participants who were hospitalized for COVID-19
Coronavirus Clinical Trial 2023: Aerobic Exercise Therapy Highlights & Side Effects. Trial Name: NCT04824443 — Phase 1
Aerobic Exercise Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT04824443 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any potential risks associated with Aerobic Exercise Therapy?

"Due to limited data on the efficacy and safety of Aerobic Exercise Therapy, our team at Power gave this intervention a rating of 1."

Answered by AI

How many people are taking part in this experiment?

"Correct. Evidence hosted on clinicaltrials.gov attests to the fact that, as of June 24th 2022, this medical trial is actively recruiting volunteers; it was first posted on March 29th 2021 and requires a total of 20 participants from 7 hospitals or clinics."

Answered by AI

Could you provide me with information regarding available slots for this trial?

"Affirmative. According to the information posted on clinicaltrials.gov, this trial is open for enrollment and has been since March 29th 2021. The last time it was edited was June 24th 2022 and 20 individuals are being recruited from a total of 7 locations."

Answered by AI

What is the scope of medical facilities participating in this research?

"Presently, this trial is running out of 7 different medical sites, with four based in Commack, Middletown and Basking Ridge. Moreover, there are 3 additional locations to choose from. It would be prudent to pick the closest centre for convenience should you decide to partake in the study."

Answered by AI
~1 spots leftby Apr 2025